瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
瑞康医药(002589) 利润表
单位:万元
报表日期2020-09-302020-06-302020-03-312019-12-312019-09-30
一、营业总收入2,000,459.291,268,688.38576,363.773,525,850.952,694,432.42
营业收入2,000,459.291,268,688.38576,363.773,525,850.952,694,432.42
二、营业总成本1,916,391.171,216,890.70555,360.373,351,724.202,555,372.25
营业成本1,619,871.591,031,206.09470,497.682,843,937.102,172,121.26
营业税金及附加7,455.464,720.311,796.7314,194.5710,698.96
销售费用156,448.7293,795.2738,773.75264,917.61199,737.53
管理费用84,951.0954,811.0726,831.78145,305.64107,437.19
财务费用46,918.9431,855.9417,190.8082,672.1865,377.30
研发费用745.35502.03269.65697.11--
资产减值损失----------
公允价值变动收益2,785.11337.11-16,065.0017,469.22-8,443.50
投资收益8,484.137,991.4318,820.305,963.136,367.07
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润90,553.6255,035.6519,744.3812,972.20130,413.13
加:营业外收入1,349.24672.86200.051,545.851,622.53
减:营业外支出4,322.733,074.222,087.104,280.471,857.85
其中:非流动资产处置损失----------
四、利润总额87,580.1352,634.3017,857.3310,237.57130,177.80
减:所得税费用24,348.6413,060.111,827.2653,735.5735,688.71
五、净利润63,231.4939,574.1916,030.07-43,497.9994,489.09
归属于母公司所有者的净利润30,871.9121,030.039,560.51-92,780.2457,865.87
少数股东损益32,359.5818,544.166,469.5549,282.2536,623.22
六、每股收益
基本每股收益(元/股)0.20500.14000.0600-0.62000.3850
稀释每股收益(元/股)0.20500.14000.0600-0.62000.3850
七、其他综合收益----------
八、综合收益总额63,231.4939,574.1916,030.07-43,497.9994,489.09
归属于母公司所有者的综合收益总额30,871.9121,030.039,560.51-92,780.2457,865.87
归属于少数股东的综合收益总额32,359.5818,544.166,469.5549,282.2536,623.22
下载全部历史数据到excel中 返回页顶